http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1489104-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4acae202b6a15394281949545e70d2f6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-224
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-234
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-224
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-06
filingDate 1975-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1977-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1489104-A
titleOfInvention 4-o-alpha,d-glucopyranosyl-6-o-alpha,d-xylo-hexopyranosyl-2-deoxystreptamine a process for its preparation and compositions incorporating it
abstract 1489104 A 4-O-α,D-glucopyranosyl-6-O- α,D - xylohexopyranosyl - 2 - deoxystreptamine ROUSSEL-UCLAF 12 March 1975 [12 March 1974] 10271/75 Heading C2C Novel compound Iα and acid addition salts thereof is prepared by alkaline hydrolysis of a compound XIIα or a mixture thereof with the #-anomer and, if necessary, separating the compound Iα from its #-anomer. Compound XIIα and its #-anomer are prepared by Konigs-Knorr condensation of a compound X with a compound VII and hydrogenolysis of the benzyl group. Compound X is prepared by acid hydrolysis of 3<SP>1</SP>,4<SP>1</SP> - di - O - acetyl - 5,6 - O - cyclohexylidenetetra - N - methoxycarbonyl - neamine which is prepared by acetylation of 5,6-O-cyolohexylidene-tetra-N-methoxycarbonyl-neamine. Compound VII is prepared from compound II by demethylation of the NH-CH 3 group followed by reaction with Cl-COOEt to give NH-COOC 2 H 5 benzylation of the 2-OH group, substitution of 1-OC 2 H 5 by 1-OCOCH, and chlorination to give 1-Cl. Compound (Iα) has antibiotic activity and forms with a suitable vehicle a pharmaceutical composition which may be administered orally, parenterally, rectally or topically.
priorityDate 1974-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455824109

Total number of triples: 18.